By the end of this webinar, participants should be able to:
- Understand oral therapy and monitoring essentials specific to Zejula® in ovarian cancer.
- Apply proactive approaches to adverse event management.
- Analyse case studies to explore real-world management of side effects and long-term monitoring success.
- Educate and support patients in managing their own care and recognising when to report symptoms.
- Utilise practical tools and strategies to optimise outcomes for patients on oral ovarian cancer therapies.